Huntington’s Disease

What is Huntington’s disease?

Huntington’s disease is an inherited condition in which nerve cells in certain parts of the brain gradually break down and die. It is described as a neurodegenerative disease, which means it involves the progressive loss of brain cells over time. The areas most affected early on are deep brain structures called the basal ganglia, which help control movement, and later the outer layer of the brain, the cortex, which supports thinking and behavior.

The condition is caused by a change in a single gene, and it is passed from parent to child. Symptoms most often begin between the ages of 30 and 50, although they can appear earlier or later. A less common form, called juvenile Huntington’s disease, begins before age 20. Huntington’s disease affects men and women equally and occurs in people of every ethnic background, though it is considered a rare disease overall.

Because Huntington’s disease affects movement, thinking, and mood at the same time, it is usually managed by a team led by a neurologist, a doctor who specializes in disorders of the brain and nervous system. In many hospital groups, including Acibadem, this care is coordinated through the neurology department alongside psychiatry, physical therapy, and other support services.

Huntington’s disease symptoms

Huntington’s disease symptoms fall into three broad groups: movement problems, changes in thinking, and changes in mood or behavior. Not everyone experiences the same combination, and symptoms often develop slowly over years. Family members frequently notice changes before the person does.

• Involuntary movements: brief, jerky, or writhing movements of the face, limbs, or trunk that the person cannot control. The medical term for this is chorea.
• Clumsiness and poor balance: dropping objects, tripping, or unsteady walking.
• Slow or rigid movements: stiffness and difficulty starting movements, especially in later stages or in the juvenile form.
• Difficulty with speech and swallowing: slurred speech and choking or coughing during meals.
• Problems with planning and organizing: trouble focusing, multitasking, or finishing tasks.
• Memory and learning difficulties: particularly with recalling new information.
• Impulsive behavior and irritability: outbursts, poor judgment, or lack of awareness of one’s own actions.
• Depression, anxiety, and apathy: low mood, worry, or loss of interest and motivation.
• Weight loss: often despite adequate eating, partly because constant movement uses energy and swallowing becomes harder.

Early stage. In the early years, symptoms may be subtle. A person may seem more forgetful, moody, or restless. Small fidgety movements may be mistaken for nervousness. Many people continue to work and live independently at this stage.

Middle stage. Chorea usually becomes more obvious and can interfere with daily tasks such as dressing, writing, or driving. Speech may become harder to understand, and thinking difficulties often begin to affect work and household decisions. Mood symptoms may become more prominent.

Late stage. Over time, involuntary movements may actually lessen and be replaced by stiffness and very slow movement. People in the late stage usually need full-time care, often cannot speak clearly, and have significant difficulty swallowing. Complications such as pneumonia, infections, injuries from falls, and problems related to poor nutrition become the main medical concerns.

Juvenile Huntington’s disease. When symptoms begin in childhood or adolescence, the picture is often different. Chorea is less common, and stiffness, slowness, clumsiness, and a decline in school performance are more typical. Seizures, which are rare in adults with the condition, occur in a proportion of young people with the juvenile form.

Causes and risk factors

Huntington’s disease causes come down to a single genetic change. The condition results from a mutation in a gene called HTT, located on chromosome 4. This gene carries the instructions for making a protein called huntingtin. Within the gene, a small segment of genetic code, known as a CAG repeat, is normally repeated a limited number of times. In people with Huntington’s disease, this segment is repeated too many times. The expanded gene produces an abnormal form of the huntingtin protein that gradually damages and kills nerve cells.

The disease follows an autosomal dominant pattern of inheritance. “Autosomal” means the gene is not on a sex chromosome, so males and females are affected equally. “Dominant” means that only one copy of the altered gene is needed to cause the disease. Each child of a parent who carries the expanded gene has a 50 percent chance of inheriting it. A person who does not inherit the expanded gene will not develop the disease and cannot pass it on.

Key points about causes and risk include the following:

• Family history is by far the most important risk factor. Almost everyone with Huntington’s disease has a parent who also carried the gene.
• Number of CAG repeats influences the disease. Larger repeat expansions are generally associated with earlier onset. Very large expansions are linked to the juvenile form.
• Parent of origin matters in some cases. The repeat can grow larger when the gene is passed on, and this happens more often when it is inherited from the father. This is one reason juvenile cases more commonly have an affected father.
• New mutations are uncommon but possible. Occasionally a person develops the disease with no known family history, sometimes because a parent died before symptoms appeared, was misdiagnosed, or had a repeat size at the borderline.

Huntington’s disease is not caused by lifestyle, diet, infection, or injury, and it is not contagious. Nothing a person does causes or prevents the underlying gene change.

How Huntington’s disease diagnosis is made

Huntington’s disease diagnosis rests on three elements: a careful neurological examination, a detailed family history, and genetic testing. Doctors may also use brain imaging and other tests to rule out conditions that can look similar.

Medical and family history. The doctor will ask about the timing and nature of symptoms, changes in mood or behavior, and whether any relatives have had similar problems, unexplained psychiatric illness, or movement disorders. Because the condition is inherited, a clear family history strongly supports the diagnosis, though its absence does not rule it out.

Neurological examination. The neurologist assesses movement, coordination, reflexes, eye movements, balance, and walking. Standardized rating scales are often used to record the type and severity of motor signs so that changes can be tracked over time.

Cognitive and psychiatric assessment. Simple tests of memory, attention, and problem-solving help document thinking changes. A psychiatrist or psychologist may evaluate mood, behavior, and the risk of depression, which is common in this condition.

Genetic testing. This is the definitive test. A blood sample is analyzed to count the number of CAG repeats in the HTT gene. In general, a result of 40 or more repeats is considered fully penetrant, meaning the person will develop the disease if they live long enough. Results between 36 and 39 are associated with reduced penetrance, meaning the disease may develop later or, in some cases, not at all. Fewer than 36 repeats is considered normal, although the intermediate range (27 to 35) can occasionally expand when passed to children. A genetic counselor usually explains these results, because the implications for the individual and their relatives are significant.

Predictive testing. Adults who have a family history but no symptoms may choose to be tested to learn whether they carry the gene. This is a personal decision with emotional, family, and practical consequences, so it is normally offered only with counseling before and after the test. Testing children who have no symptoms is generally not recommended.

Brain imaging. Magnetic resonance imaging (MRI) or computed tomography (CT) may show shrinkage of the basal ganglia, especially in structures called the caudate and putamen. Imaging cannot diagnose Huntington’s disease on its own, but it can support the diagnosis and exclude other causes such as stroke or tumor.

Other tests. Blood tests may be used to rule out conditions that mimic Huntington’s disease, including thyroid disorders, Wilson’s disease (a copper storage disorder), and certain other inherited movement disorders.

Huntington’s disease treatment options

There is currently no treatment that cures Huntington’s disease or reliably stops its progression. Huntington’s disease treatment options therefore focus on easing symptoms, maintaining function and independence for as long as possible, and supporting the person and their family. Care plans are individualized and adjusted as needs change.

Observation and regular follow-up. People with mild early symptoms or those who carry the gene but have no symptoms may not need medication right away. Regular reviews with a neurologist allow changes to be identified early and treatment to be started when it is likely to help.

Medications for movement symptoms. Drugs that reduce chorea are available and may be considered when involuntary movements interfere with daily life or cause distress. Medications such as tetrabenazine and deutetrabenazine work by lowering the amount of the brain chemical dopamine that is available to nerve cells. Certain antipsychotic medications can also reduce chorea and may be chosen when irritability or psychotic symptoms are present at the same time. All of these drugs can have side effects, including drowsiness, worsening of depression, or stiffness, so doctors weigh benefits and risks carefully and monitor closely.

Medications for mood and behavior. Depression and anxiety are common and treatable. Antidepressants, particularly a class known as selective serotonin reuptake inhibitors (SSRIs), are often used. Mood stabilizers or antipsychotic medications may be considered for severe irritability, aggression, or hallucinations. Sleep difficulties may also be addressed with medication or behavioral strategies.

Medications for thinking problems. No drug has been clearly shown to improve the cognitive decline of Huntington’s disease. Management relies mainly on practical strategies, routines, and environmental adjustments.

Rehabilitation and therapies. Non-drug approaches are a central part of care:

• Physical therapy helps maintain strength, flexibility, and balance and may reduce the risk of falls.
• Occupational therapy focuses on adapting daily tasks, home safety, and assistive devices such as weighted utensils or grab bars.
• Speech and language therapy supports clear speech, communication aids, and safe swallowing techniques.
• Nutritional support from a dietitian helps counter weight loss, often through higher-calorie meals and textures that are easier to swallow.
• Psychological support for the person and family, including counseling and support groups.

Procedures and surgery. Surgery is not a standard treatment for Huntington’s disease. Deep brain stimulation, a procedure in which electrodes are placed in the brain, has been studied in small numbers of people with severe chorea, but it remains experimental for this condition. In later stages, a feeding tube may be discussed if swallowing becomes unsafe; this is a personal decision that ideally is made in advance with the person’s wishes documented.

Research and clinical trials. Scientists are studying treatments aimed at lowering the production of the abnormal huntingtin protein, as well as other approaches to slow the disease. These remain under investigation, and your doctor may discuss whether participation in a clinical trial is appropriate.

Living with Huntington’s disease and outlook

Huntington’s disease is a progressive, life-limiting condition. After symptoms begin, the disease typically advances over many years, often over one to three decades, although the pace varies considerably from person to person. Juvenile-onset disease tends to progress more quickly. Death usually results from complications such as pneumonia, other infections, injuries from falls, or heart problems rather than from the disease itself.

Despite this outlook, many people live meaningful lives for years after diagnosis, and good supportive care can make a real difference to comfort, safety, and quality of life. Helpful measures often include:

• Keeping to structured daily routines and using reminders, lists, and calendars.
• Making the home safer by removing tripping hazards, padding sharp corners, and installing rails.
• Eating small, frequent, high-calorie meals and following swallowing advice.
• Staying physically active within one’s abilities.
• Planning ahead for work, finances, driving, and future care preferences while decision-making ability is intact.
• Seeking counseling or support groups for both the person and caregivers.

Caregivers face significant physical and emotional demands. Respite care, community services, and caregiver support networks are important parts of long-term planning. Genetic counseling is also valuable for at-risk relatives who are considering testing or making decisions about having children, including options such as prenatal testing or preimplantation genetic testing with in vitro fertilization.

Frequently asked questions

What is Huntington’s disease in simple terms?

Huntington’s disease is an inherited brain disorder in which a faulty gene causes nerve cells in certain regions of the brain to gradually die. This leads to uncontrolled movements, difficulties with thinking and memory, and changes in mood and behavior that worsen over time. Symptoms usually begin in adulthood, and the condition is passed directly from an affected parent to a child.

What are the first Huntington’s disease symptoms?

Early symptoms are often subtle and vary between people. They may include small involuntary movements or fidgeting, clumsiness, difficulty concentrating or organizing tasks, irritability, low mood, or changes in personality. Because these signs can have many other causes, they should be evaluated by a doctor rather than assumed to be Huntington’s disease, especially if there is a family history.

What are the Huntington’s disease causes, and is it always inherited?

The cause is an expansion of a repeated segment of DNA in the HTT gene, which produces a harmful form of the huntingtin protein. In the vast majority of cases the expanded gene is inherited from a parent. Rarely, the disease appears with no known family history, usually because a parent died early, was never diagnosed, or carried a borderline repeat size that expanded when passed on.

How is Huntington’s disease diagnosis confirmed?

A neurologist examines movement, coordination, thinking, and mood, and reviews the family history. The diagnosis is confirmed with a genetic blood test that counts the CAG repeats in the HTT gene. Brain imaging and other blood tests may be used to exclude conditions that can look similar. Genetic counseling is usually offered before and after testing.

Can Huntington’s disease be cured, and what are the treatment options?

There is no cure at present. Huntington’s disease treatment options aim to control symptoms and maintain quality of life. These include medications for involuntary movements, depression, anxiety, and irritability, along with physical, occupational, and speech therapy, nutritional support, and psychological care. Research into therapies that target the underlying gene is ongoing, but these are not yet established treatments.

Should I get tested if a parent has Huntington’s disease?

This is a deeply personal decision. Predictive genetic testing can tell an adult whether they carry the expanded gene, but it cannot predict exactly when symptoms will start. Some people want the information for planning, while others prefer not to know. Genetic counselors help people think through the emotional, family, insurance, and practical implications before deciding.

Does Huntington’s disease affect life expectancy?

Yes. Huntington’s disease shortens life, with progression typically occurring over many years after symptoms begin. The rate of decline varies widely between individuals. Most deaths result from complications such as pneumonia, infections, or injuries rather than from the disease directly, which is why attention to swallowing safety, nutrition, fall prevention, and infection prevention is so important.

When to see a doctor

Anyone who has a family history of Huntington’s disease and notices new movement, thinking, or mood changes should speak with a doctor. Adults who want to discuss predictive genetic testing can ask for a referral to a neurologist or genetic counselor. People already diagnosed should have regular follow-up so that treatment can be adjusted as symptoms change.

Seek urgent medical attention if any of the following occur:

• Choking, difficulty breathing, or repeated coughing during or after eating, which may signal food or liquid entering the airway.
• Fever, cough, or chest symptoms, which may indicate pneumonia, a common and serious complication.
• A fall with head injury, loss of consciousness, or inability to move a limb.
• Thoughts of self-harm or suicide, or statements about not wanting to live; depression is common in this condition and requires prompt help.
• Sudden severe agitation, aggression, or confusion that puts the person or others at risk.
• Inability to swallow medications or fluids, or signs of dehydration such as very little urine, dizziness, or extreme drowsiness.
• A first seizure, or a seizure lasting more than a few minutes.
• Rapid, unexplained weight loss over a short period.

Prompt attention to these warning signs can prevent serious complications and helps the care team keep the person as safe and comfortable as possible.